An immunohistochemistry study on normal prostate tissues, primary tumors, and bone metastasis samples obtained from patients revealed that CCN3 expression levels were higher in patients with bone metastasis and positively correlated with malignancy in human prostate cancer cells. The gene discussed is CCN3; the disease is prostate cancer.